Nebula Research & Development’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$247K	Buy	+100,780	New	+$247K	0.02%	836
2023 Q4	–	Sell	-21,435	Closed	-$439K	–	842
2023 Q3	$439K	Buy	+21,435	New	+$439K	0.23%	157